F.D.A. Panel Recommends R.S.V. Shot to Protect Infants
The News A Food and Drug Administration advisory panel recommended approval of a monoclonal antibody shot aimed at preventing a potentially lethal pathogen, respiratory syncytial virus, or R.S.V., in infants and vulnerable toddlers. The treatment …
